By InvitationNot Applicable

Carbon Monoxide Blood and DNA Biorepository

United States300 participantsStarted 2012-02

Plain-language summary

The purpose of this biorepository is to collect blood from patients at the time of CO poisoning and at follow-up visits months to years later. These samples can be used in the future to learn more about how CO damages the heart and brain and whether blood tests could predict which patients will have problems after CO poisoning.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Symptomatic carbon monoxide poisoning (headache, nausea, vomiting, dizziness, fatigue, muscle aches, slowed mentation, confusion, loss of consciousness, etc.).
✓. Documented exposure to carbon monoxide and no other reasonable explanation for their signs and symptoms.

Exclusion criteria

✕. Pregnancy
✕. Age \< 18 years
✕. Unable to obtain informed consent
✕. Subjects who, in the opinion of the investigator, are unable to comply with the requirements of the study or are unsuitable for any reason. The investigator and the Sponsor, prior to enrolling the subject on a case-by-case basis, must approve and document any waiver of these inclusion and exclusion criteria.
✕. Anemia requiring blood products within the last 4 months or hematocrit less than the laboratory normal reference range

What they're measuring

Biorepository for serum and plasma

Timeframe: Within 24 hours of CO Poisoning

Trial details

NCT IDNCT01758653

SponsorIntermountain Health Care, Inc.

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2032-12

View on ClinicalTrials.gov More Carbon Monoxide Poisoning trials